External organization PPD Germany GmbH & Co. KG

Basic data

Name:

PPD Germany GmbH & Co. KG

Country:

Germany

Region/province:

Bayern

City:

Nürnberg

URL:

http://www.ppdi.com/

Projects

A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF MPDL3280A (ANTI PD-L1 ANTIBODY) IN COMBINATION WITH CARBOPLATIN NAB-PACLITAXEL FOR CHEMOTHERAPY NAIVE PATIENTS WITH STAGE IV NON-SQUAMOUS NON SMALL CELL LUNG CANCER

2016 - 2019

PPD Germany GmbH & Co. KG

AUGUSTUS – An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety ofApixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and AcuteCoronary Syndrome or Percutaneous Coronary Intervention

2017 - 2019

PPD Germany GmbH & Co. KG

Klinische Studie

2015 - 2017

PPD Germany GmbH & Co. KG

Help

will be deleted permanently. This cannot be undone.